|
Research Programmes |
|
 |
Sixth Framework Programme (2002-2006) |
|
Fifth
Framework Programme (1998-2002) |
|
Frequently Asked Questions |
|
Fourth Framework Programme (1994-1998) |
| What's new? | |
 Press release
|
|
|
Brussels, 21 May 2001
Key words: health, medical research, European co-operation See also the press release of 10 May 2001: Human health: the contribution of European research On Monday 21 May at 11.00 am, in the presence of Philippe Busquin, European Commissioner for research, and Antoine Durrleman, Director-General of the Assistance Publique-Hôpitaux de Paris, several significant advances achieved by European projects in the field of medical research will be presented to the press. The results, which include the establishment of an umbilical-cord blood bank to help children suffering from leukaemia, and studies on healthcare for premature babies and intensive care in general, show how necessary it is to tackle certain research subjects at a European level. Medical research is one of the areas where the importance and added value of European research are clearly demonstrated. Be it rare (orphan) diseases, epidemiological studies, understanding of diseases involving complex mechanisms (including cancer), elaboration of sophisticated treatments, exchange of good practices or urgent response to some crisis, such as mad cow disease, all these issues are more effectively dealt with if tackled at the European level. This is reflected by the fact that the budget allocated by the Union to medical research has more than doubled during the last ten years (amounting to some EUR 1.7 billion for the period 1998-2002). Results to be presented
The project has established an umbilical-cord blood bank and a network to analyse transplants made in the European Union. This project follows a recent discovery of specific properties of umbilical-cord blood taken at birth which allow its utilisation for transplants in children suffering from leukaemia and other hereditary bone-marrow diseases.
Study of the variability of healthcare given to highly premature babies in the European Union: which is the better organisational model - the large maternity units of northern Europe or the small ones in the south?
Assessment of intensive care through the development of a standard European method for the collection of patient data such as co-morbidity, diagnosis, and severity. The aim is to improve the outcome of intensive care in the European Union.
Presentation of a study which has resulted in a better understanding of how the brain is protected during foetal development. This public health priority also aims at improving the diagnosis and treatment of other neurological syndromes.
Address: Contacts:
Carmelita Stoffels, Assistance Publique-Hôpitaux de Paris, Michel Claessens, Communication Unit, Research DG |
